Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,570 | 259 | 99.3% |
| Education | $33.30 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $940.63 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $687.20 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $455.77 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $443.20 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $386.96 | 19 | $0 (2024) |
| Celgene Corporation | $261.16 | 20 | $0 (2024) |
| Lilly USA, LLC | $186.77 | 7 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $172.54 | 4 | $0 (2024) |
| Amgen Inc. | $135.16 | 7 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $129.45 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,672 | 85 | Janssen Biotech, Inc. ($309.67) |
| 2023 | $1,536 | 92 | ABBVIE INC. ($444.85) |
| 2022 | $1,086 | 68 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($272.62) |
| 2021 | $309.76 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($93.45) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Immunology | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $100.85 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: GI | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 469 | 495 | $228,782 | $43,554 |
| 2022 | 13 | 439 | 4,896 | $385,107 | $121,527 |
| 2021 | 15 | 567 | 1,415 | $381,986 | $79,577 |
| 2020 | 9 | 211 | 217 | $102,767 | $15,067 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 80 | 84 | $75,600 | $15,596 | 20.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 83 | 85 | $46,750 | $6,349 | 13.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 53 | 54 | $39,420 | $5,538 | 14.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $11,900 | $2,756 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 37 | $5,069 | $2,333 | 46.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,200 | $2,057 | 39.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $8,400 | $2,006 | 23.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 15 | $4,950 | $1,411 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,900 | $1,366 | 35.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $7,700 | $1,313 | 17.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 11 | $6,270 | $1,223 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $2,055 | $829.86 | 40.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 14 | 14 | $2,856 | $406.00 | 14.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 91 | 99 | $8,712 | $371.75 | 4.3% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 11 | 3,600 | $100,800 | $61,327 | 60.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 14 | 860 | $94,600 | $24,636 | 26.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 75 | 76 | $67,320 | $14,059 | 20.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 89 | 91 | $48,730 | $6,402 | 13.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 39 | 41 | $29,080 | $3,831 | 13.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 42 | $5,754 | $2,645 | 46.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 18 | 19 | $6,270 | $1,822 | 29.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $9,610 | $1,773 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,400 | $1,747 | 39.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 24 | $3,288 | $1,277 | 38.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 11 | 11 | $5,570 | $1,107 | 19.9% |
About Dr. Christopher Mulder, DO
Dr. Christopher Mulder, DO is a Internal Medicine healthcare provider based in Clive, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356577951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Mulder, DO has received a total of $4,603 in payments from pharmaceutical and medical device companies, with $1,672 received in 2024. These payments were reported across 261 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,570).
As a Medicare-enrolled provider, Mulder has provided services to 1,686 Medicare beneficiaries, totaling 7,023 services with total Medicare billing of $259,725. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Clive, IA
- Active Since 06/09/2009
- Last Updated 11/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356577951
Products in Payments
- SKYRIZI (Biological) $396.36
- STELARA (Biological) $339.37
- RINVOQ (Biological) $314.73
- DUPIXENT (Biological) $304.96
- ENTYVIO (Biological) $293.23
- ZEPOSIA (Drug) $291.54
- XIFAXAN (Drug) $250.14
- TRULANCE (Drug) $193.06
- REMICADE (Biological) $186.87
- VOQUEZNA (Drug) $172.54
- TREMFYA (Drug) $160.96
- OMVOH (Drug) $154.88
- Linzess (Drug) $129.45
- IBSRELA (Drug) $121.24
- GATTEX (Drug) $105.29
- DIFICID (Drug) $88.95
- XELJANZ (Drug) $85.05
- HUMIRA (Biological) $81.60
- VIBERZI (Drug) $75.55
- AMJEVITA (Biological) $68.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clive
Benjamin Pottebaum, D.o, D.O
Internal Medicine — Payments: $5,952
Rajalakshmi Iyer, Md, MD
Internal Medicine — Payments: $2,542
Abdillahi Abdinoor, Md, MD
Internal Medicine — Payments: $1,396
Stephen Hoelscher, Md, MD
Internal Medicine — Payments: $1,086
Bernard Feldman, D.o, D.O
Internal Medicine — Payments: $962.36
Anthony Kopp, Do, DO
Internal Medicine — Payments: $621.44